Related Experiment Video

Updated: May 2, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

18.8K

Congenital dyserythropoietic anemia type I: report of a case

A Kumar1, R Kushwaha1, U S Singh1

  • 1Department of Pathology, C.S.M. Medical University (erstwhile KGMC), Lucknow, India.

Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|February 21, 2014
PubMed

Insights

Congenital dyserythropoietic anemia type I (CDA I) is a rare genetic disorder. Diagnosis of CDA I can be reliably achieved through careful bone marrow examination, especially in regions like the Indian subcontinent where it is infrequently reported.

Area of Science:

  • Hematology
  • Genetics
  • Rare Diseases

Background:

  • Congenital dyserythropoietic anemias (CDAs) are rare inherited disorders affecting red blood cell production (erythropoiesis).
  • CDAs are characterized by ineffective erythropoiesis and specific abnormalities in erythroblasts within the bone marrow.
  • Congenital dyserythropoietic anemia type I (CDA I) is an autosomal recessive subtype associated with ineffective erythropoiesis and iron overload.

Observation:

  • This report details a case of CDA I from the Indian subcontinent.
  • The case underscores the diagnostic utility of bone marrow aspirate examination.

Findings:

  • Morphologic abnormalities in erythroblasts are characteristic of CDAs.
  • Careful examination of bone marrow aspirate is crucial for diagnosing CDA I.
  • Ineffective erythropoiesis is the primary driver of anemia in CDA I.

Implications:

  • Increased awareness and reporting of CDA I cases are needed, especially from underrepresented regions.
  • Bone marrow morphology remains a key diagnostic tool for CDA I.
  • Early and accurate diagnosis can guide management of iron overload and anemia.

Keywords:
AnemiaBone marrowCongenital Dyserythropoietic-type 1

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

6.8K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

1.1K

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K
Erythropoiesis01:14

Erythropoiesis

4.0K